These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8238359)

  • 1. Role of histamine2 receptor in increased expression of rat gastric H(+)-K(+)-ATPase alpha-subunit induced by omeprazole.
    Tari A; Yamamoto G; Sumii K; Sumii M; Takehara Y; Haruma K; Kajiyama G; Wu V; Sachs G; Walsh JH
    Am J Physiol; 1993 Oct; 265(4 Pt 1):G752-8. PubMed ID: 8238359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of histamine on rat gastric H(+)-K(+)-ATPase alpha-subunit expression.
    Tari A; Yamamoto G; Yonei Y; Sumii M; Sumii K; Haruma K; Kajiyama G; Wu V; Sachs G; Walsh JH
    Am J Physiol; 1994 Mar; 266(3 Pt 1):G444-50. PubMed ID: 8166283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famotidine, a histamine-2-receptor antagonist, inhibits the increase in rat gastric H+/K(+)-ATPase mRNA induced by intravenous infusion of gastrin 17 and histamine.
    Yamamoto G; Tari A; Sumii K; Sumii M; Haruma K; Kajiyama G
    Dig Dis Sci; 1995 Sep; 40(9):2064-9. PubMed ID: 7555465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the gastric H+/K(+)-ATPase and histidine decarboxylase during omeprazole treatment.
    Swarovsky B; Eissele R; Gross M; Körtner G; Koop H; Arnold R; Simon B
    Digestion; 1994; 55(2):97-102. PubMed ID: 8187977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of rat gastric H+/K(+)-ATPase alpha-subunit mRNA by omeprazole.
    Tari A; Wu V; Sumii M; Sachs G; Walsh JH
    Biochim Biophys Acta; 1991 Dec; 1129(1):49-56. PubMed ID: 1684516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion.
    Gedda K; Scott D; Besancon M; Lorentzon P; Sachs G
    Gastroenterology; 1995 Oct; 109(4):1134-41. PubMed ID: 7557078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
    Scott DR; Besancon M; Sachs G; Helander H
    Dig Dis Sci; 1994 Oct; 39(10):2118-26. PubMed ID: 7924730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid secretion and the H,K ATPase of stomach.
    Prinz C; Kajimura M; Scott D; Helander H; Shin J; Besancon M; Bamberg K; Hersey S; Sachs G
    Yale J Biol Med; 1992; 65(6):577-96. PubMed ID: 1341065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat.
    Tari A; Kamiyasu T; Yonei Y; Hamada M; Sumii M; Sumii K; Kajiyama G; Dimaline R
    Dig Dis Sci; 1997 Sep; 42(9):1901-7. PubMed ID: 9331153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
    Odiase E; Zhang X; Chang Y; Nelson M; Balaji U; Gu J; Zhang Q; Pan Z; Spechler SJ; Souza RF
    Gastroenterology; 2021 May; 160(6):2072-2088.e6. PubMed ID: 33581123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
    Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive regulation of the enzymatic activity of gastric H(+),K(+)-ATPase by sialylation of its β-subunit.
    Fujii T; Watanabe M; Shimizu T; Takeshima H; Kushiro K; Takai M; Sakai H
    Biochim Biophys Acta; 2016 Jun; 1858(6):1228-35. PubMed ID: 26922883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach.
    Tari A; Kuruhara Y; Yonei Y; Yamauchi R; Okahara S; Sumii K; Kajiyama G
    J Gastroenterol; 2001 Jun; 36(6):375-85. PubMed ID: 11428583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immuno- and enzyme cytochemical study of the H(+)-K+ ATPase in human parietal cells after administration of tetragastrin and omeprazole.
    Kobayashi A; Araki K; Ando T; Ogata T
    Arch Histol Cytol; 1997 Jun; 60(2):205-14. PubMed ID: 9232184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
    Nishida A; Kobayashi-Uchida A; Akuzawa S; Takinami Y; Shishido T; Kamato T; Ito H; Yamano M; Yuki H; Nagakura Y
    Am J Physiol; 1995 Nov; 269(5 Pt 1):G699-705. PubMed ID: 7491961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells.
    Karam SM; Forte JG
    Am J Physiol; 1994 Apr; 266(4 Pt 1):G745-58. PubMed ID: 8179010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.